| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.31e-06 | 26 | 73 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.66e-05 | 14 | 73 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.90e-05 | 52 | 73 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.15e-04 | 26 | 73 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.56e-04 | 343 | 73 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.67e-04 | 459 | 73 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 6.50e-04 | 525 | 73 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.58e-04 | 526 | 73 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.00e-03 | 13 | 73 | 2 | GO:0004126 | |
| GeneOntologyBiologicalProcess | heart contraction | 9.28e-06 | 298 | 72 | 8 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 1.21e-05 | 309 | 72 | 8 | GO:0003015 | |
| GeneOntologyBiologicalProcess | blood circulation | SEMA3A SLIT2 KAT2B SCN1A SCN3A SCN7A SCN8A GCGR MDM4 CHRM3 SMAD7 | 1.43e-05 | 648 | 72 | 11 | GO:0008015 |
| GeneOntologyBiologicalProcess | circulatory system process | SEMA3A SLIT2 KAT2B SCN1A SCN3A SCN7A SCN8A GCGR MDM4 CHRM3 SMAD7 | 4.44e-05 | 733 | 72 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 6.53e-05 | 62 | 72 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 6.54e-05 | 121 | 72 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.79e-04 | 6 | 72 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.79e-04 | 6 | 72 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.44e-04 | 87 | 72 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.68e-04 | 36 | 72 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.96e-04 | 167 | 72 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.15e-04 | 93 | 72 | 4 | GO:0086003 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.15e-07 | 17 | 73 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.04e-06 | 29 | 73 | 4 | GO:0034706 | |
| Domain | Na_channel_asu | 4.19e-08 | 10 | 72 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 4.19e-08 | 10 | 72 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 4.19e-08 | 10 | 72 | 4 | PF06512 | |
| Domain | Na_trans_cytopl | 1.09e-06 | 6 | 72 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 1.09e-06 | 6 | 72 | 3 | IPR024583 | |
| Domain | C_TYPE_LECTIN_1 | 1.42e-05 | 80 | 72 | 5 | PS00615 | |
| Domain | Lectin_C | 1.80e-05 | 84 | 72 | 5 | PF00059 | |
| Domain | CLECT | 1.80e-05 | 84 | 72 | 5 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 1.91e-05 | 85 | 72 | 5 | PS50041 | |
| Domain | C-type_lectin-like | 2.02e-05 | 86 | 72 | 5 | IPR001304 | |
| Domain | C-type_lectin_CS | 2.24e-05 | 43 | 72 | 4 | IPR018378 | |
| Domain | C-type_lectin-like/link | 3.99e-05 | 99 | 72 | 5 | IPR016186 | |
| Domain | CTDL_fold | 5.79e-05 | 107 | 72 | 5 | IPR016187 | |
| Domain | Channel_four-helix_dom | 6.87e-05 | 57 | 72 | 4 | IPR027359 | |
| Domain | - | 6.87e-05 | 57 | 72 | 4 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 7.84e-05 | 114 | 72 | 5 | IPR005821 | |
| Domain | Ion_trans | 7.84e-05 | 114 | 72 | 5 | PF00520 | |
| Domain | Sec23/24_helical_dom | 2.18e-04 | 6 | 72 | 2 | IPR006900 | |
| Domain | Sec23_24_beta_S | 2.18e-04 | 6 | 72 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 2.18e-04 | 6 | 72 | 2 | PF04810 | |
| Domain | Sec23_trunk | 2.18e-04 | 6 | 72 | 2 | PF04811 | |
| Domain | Sec23_helical | 2.18e-04 | 6 | 72 | 2 | PF04815 | |
| Domain | Sec23_BS | 2.18e-04 | 6 | 72 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 2.18e-04 | 6 | 72 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 2.18e-04 | 6 | 72 | 2 | IPR006895 | |
| Domain | IQ | 2.70e-04 | 81 | 72 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.04e-04 | 90 | 72 | 4 | IPR000048 | |
| Domain | - | 5.37e-04 | 97 | 72 | 4 | 3.10.100.10 | |
| Domain | EF-hand-dom_pair | 8.35e-04 | 287 | 72 | 6 | IPR011992 | |
| Domain | APOBEC_N | 9.43e-04 | 12 | 72 | 2 | PF08210 | |
| Domain | APOBEC_N | 9.43e-04 | 12 | 72 | 2 | IPR013158 | |
| Domain | Gelsolin | 1.29e-03 | 14 | 72 | 2 | PF00626 | |
| Domain | FN_type2_col-bd | 1.29e-03 | 14 | 72 | 2 | IPR000562 | |
| Domain | FN2_2 | 1.29e-03 | 14 | 72 | 2 | PS51092 | |
| Domain | Gelsolin-like_dom | 1.29e-03 | 14 | 72 | 2 | IPR007123 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.29e-03 | 14 | 72 | 2 | IPR016192 | |
| Domain | fn2 | 1.29e-03 | 14 | 72 | 2 | PF00040 | |
| Domain | FN2_1 | 1.29e-03 | 14 | 72 | 2 | PS00023 | |
| Domain | FN2 | 1.29e-03 | 14 | 72 | 2 | SM00059 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 1.49e-03 | 15 | 72 | 2 | PS51747 | |
| Domain | Cytidine_deaminase-like | 1.92e-03 | 17 | 72 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 1.92e-03 | 17 | 72 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 1.92e-03 | 17 | 72 | 2 | IPR002125 | |
| Domain | IQ | 2.60e-03 | 71 | 72 | 3 | PF00612 | |
| Domain | ADF-H/Gelsolin-like_dom | 3.83e-03 | 24 | 72 | 2 | IPR029006 | |
| Domain | - | 3.83e-03 | 24 | 72 | 2 | 3.40.20.10 | |
| Domain | RICIN | 5.19e-03 | 28 | 72 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 5.19e-03 | 28 | 72 | 2 | PS50231 | |
| Domain | IQ | 5.56e-03 | 93 | 72 | 3 | PS50096 | |
| Domain | Ricin_B_lectin | 5.95e-03 | 30 | 72 | 2 | IPR000772 | |
| Domain | Kringle-like | 6.75e-03 | 32 | 72 | 2 | IPR013806 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.20e-06 | 31 | 53 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 5.92e-06 | 32 | 53 | 4 | M27455 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.23e-04 | 26 | 53 | 3 | M27483 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.24e-04 | 130 | 53 | 5 | M27454 | |
| Pathway | WP_DRAVET_SYNDROME | 1.54e-04 | 28 | 53 | 3 | M45519 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 2.88e-04 | 7 | 53 | 2 | MM15412 | |
| Pathway | REACTOME_MRNA_EDITING | 4.91e-04 | 9 | 53 | 2 | MM15445 | |
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 17537961 | ||
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 35031483 | ||
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 29578003 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.84e-07 | 6 | 74 | 3 | 23652591 | |
| Pubmed | 7.70e-07 | 9 | 74 | 3 | 16382098 | ||
| Pubmed | 7.70e-07 | 9 | 74 | 3 | 15746173 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.01e-06 | 12 | 74 | 3 | 30175250 | |
| Pubmed | 2.60e-06 | 13 | 74 | 3 | 15123669 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 4.13e-06 | 15 | 74 | 3 | 9726281 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 4.47e-06 | 2 | 74 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 4.47e-06 | 2 | 74 | 2 | 26410685 | |
| Pubmed | Transcription of the human sodium channel SCN1A gene is repressed by a scaffolding protein RACK1. | 4.47e-06 | 2 | 74 | 2 | 24436055 | |
| Pubmed | Cloning and functional characterization of mammalian homologues of the COPII component Sec23. | 4.47e-06 | 2 | 74 | 2 | 8898360 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 4.47e-06 | 2 | 74 | 2 | 24990319 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33411788 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31943325 | ||
| Pubmed | Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. | 4.47e-06 | 2 | 74 | 2 | 30065114 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27690330 | ||
| Pubmed | Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. | 4.47e-06 | 2 | 74 | 2 | 16285943 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 4.47e-06 | 2 | 74 | 2 | 23965409 | |
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 4.47e-06 | 2 | 74 | 2 | 37665666 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17881658 | ||
| Pubmed | Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope. | 7.37e-06 | 18 | 74 | 3 | 37914931 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.34e-05 | 3 | 74 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.34e-05 | 3 | 74 | 2 | 27602762 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.34e-05 | 3 | 74 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.34e-05 | 3 | 74 | 2 | 24577894 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.34e-05 | 3 | 74 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.34e-05 | 3 | 74 | 2 | 23533681 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 12610651 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 1541833 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 27356895 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.34e-05 | 3 | 74 | 2 | 25589647 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 33895391 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.34e-05 | 3 | 74 | 2 | 31518043 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23859570 | ||
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.34e-05 | 3 | 74 | 2 | 24840555 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 9765497 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18784617 | ||
| Pubmed | Dynamic regulation of TFH selection during the germinal centre reaction. | 1.34e-05 | 3 | 74 | 2 | 33536617 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24453360 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17544618 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23449789 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 32845893 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.34e-05 | 3 | 74 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.34e-05 | 3 | 74 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.34e-05 | 3 | 74 | 2 | 18772436 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 28518218 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 27816501 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.34e-05 | 3 | 74 | 2 | 18786991 | |
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 1.34e-05 | 3 | 74 | 2 | 24704313 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 286744 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24725948 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 20702647 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 20980520 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 284359 | ||
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 1.34e-05 | 3 | 74 | 2 | 28117367 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 20617165 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.34e-05 | 3 | 74 | 2 | 39208378 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31943071 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.34e-05 | 3 | 74 | 2 | 20566830 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17303427 | ||
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.34e-05 | 3 | 74 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.34e-05 | 3 | 74 | 2 | 25505062 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31595054 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17928448 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.34e-05 | 3 | 74 | 2 | 17967065 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 20335265 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 14973256 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.34e-05 | 3 | 74 | 2 | 29593034 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31830125 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.34e-05 | 3 | 74 | 2 | 21998583 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.34e-05 | 3 | 74 | 2 | 38115583 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 12758070 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 26182346 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.34e-05 | 3 | 74 | 2 | 35458563 | |
| Pubmed | Natural resistance to HIV infection: The Vif-APOBEC interaction. | 1.34e-05 | 3 | 74 | 2 | 17067930 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 22275865 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 1.34e-05 | 3 | 74 | 2 | 31054517 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 293683 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19150103 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.34e-05 | 3 | 74 | 2 | 12466850 | |
| Pubmed | 1.38e-05 | 22 | 74 | 3 | 35120648 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.95e-05 | 153 | 74 | 5 | 26365490 | |
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 2.67e-05 | 4 | 74 | 2 | 18983852 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 2.67e-05 | 4 | 74 | 2 | 31400166 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 23725696 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 2.67e-05 | 4 | 74 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 2.67e-05 | 4 | 74 | 2 | 26253512 | |
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 2.67e-05 | 4 | 74 | 2 | 17020885 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 20375169 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 21147467 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 16055735 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 2.67e-05 | 4 | 74 | 2 | 18572219 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 5.53e-05 | 127 | 74 | 4 | chr2q24 | |
| Cytoband | 2q24 | 1.40e-04 | 11 | 74 | 2 | 2q24 | |
| Cytoband | Xq25 | 2.02e-03 | 41 | 74 | 2 | Xq25 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.55e-06 | 9 | 49 | 3 | 1203 | |
| GeneFamily | C-type lectin domain family | 7.79e-06 | 47 | 49 | 4 | 494 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 4.67e-04 | 12 | 49 | 2 | 406 | |
| GeneFamily | Immunoglobulin like domain containing | 1.83e-03 | 193 | 49 | 4 | 594 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-08 | 169 | 74 | 7 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.42e-07 | 173 | 74 | 6 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.75e-07 | 186 | 74 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.97e-07 | 187 | 74 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.13e-07 | 192 | 74 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.38e-07 | 193 | 74 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.90e-07 | 195 | 74 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-07 | 195 | 74 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-07 | 195 | 74 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.17e-07 | 196 | 74 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.17e-07 | 196 | 74 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.73e-07 | 198 | 74 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.73e-07 | 198 | 74 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-06 | 200 | 74 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.03e-06 | 200 | 74 | 6 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.03e-06 | 200 | 74 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-06 | 200 | 74 | 6 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 200 | 74 | 6 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-06 | 200 | 74 | 6 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 200 | 74 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.03e-06 | 200 | 74 | 6 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 200 | 74 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-06 | 200 | 74 | 6 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 200 | 74 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-06 | 200 | 74 | 6 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 2.19e-06 | 126 | 74 | 5 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 5.33e-06 | 151 | 74 | 5 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.86e-06 | 154 | 74 | 5 | 835ef49d314ecbcbfd8d1041ba202a5eedcda0bd | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-06 | 164 | 74 | 5 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 9.21e-06 | 169 | 74 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 177 | 74 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 178 | 74 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.22e-05 | 179 | 74 | 5 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.22e-05 | 179 | 74 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-05 | 182 | 74 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-05 | 182 | 74 | 5 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-05 | 183 | 74 | 5 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | cellseq2-Immune-Hematopoietic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-05 | 183 | 74 | 5 | 324ec4374b552da7ce03809945b3a0798342d4ba | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 185 | 74 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 1.43e-05 | 185 | 74 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.62e-05 | 190 | 74 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-05 | 191 | 74 | 5 | 133864ec1e89f97a82c3bb01d2a3c658397fefaf | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.66e-05 | 191 | 74 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.66e-05 | 191 | 74 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.66e-05 | 191 | 74 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-05 | 191 | 74 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-05 | 192 | 74 | 5 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.70e-05 | 192 | 74 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-05 | 192 | 74 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 192 | 74 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 192 | 74 | 5 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.70e-05 | 192 | 74 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-05 | 193 | 74 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.75e-05 | 193 | 74 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-05 | 194 | 74 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 194 | 74 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.79e-05 | 194 | 74 | 5 | 866a9ca4c93c3c79c709a9d00def5392197f7e18 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.79e-05 | 194 | 74 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-05 | 195 | 74 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-05 | 195 | 74 | 5 | 8cd7667a65d77dd7b301090a9b65aba254741375 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.84e-05 | 195 | 74 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.84e-05 | 195 | 74 | 5 | 211eba45a502b961873ca2d4642f7852e6e89d7a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.84e-05 | 195 | 74 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 196 | 74 | 5 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-05 | 196 | 74 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-05 | 196 | 74 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-05 | 196 | 74 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 197 | 74 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.93e-05 | 197 | 74 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.93e-05 | 197 | 74 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 197 | 74 | 5 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.98e-05 | 198 | 74 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.98e-05 | 198 | 74 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-05 | 198 | 74 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.02e-05 | 199 | 74 | 5 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.02e-05 | 199 | 74 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.02e-05 | 199 | 74 | 5 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-05 | 199 | 74 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 200 | 74 | 5 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.07e-05 | 200 | 74 | 5 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.07e-05 | 200 | 74 | 5 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 200 | 74 | 5 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 200 | 74 | 5 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 200 | 74 | 5 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.07e-05 | 200 | 74 | 5 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | 869d45b71efd395d050873db5fee2ed0443d5e6f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 74 | 5 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 74 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 200 | 74 | 5 | 5c6520dc4c4693827f6680651785680b5883afb8 | |
| ToppCell | distal-1-Hematologic-Natural_Killer|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 74 | 5 | 69756eba4b9b6cd5115aa7b76dfc36bb70097993 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.39e-09 | 10 | 71 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.39e-09 | 10 | 71 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.50e-08 | 12 | 71 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | congenital dyserythropoietic anemia type II (implicated_via_orthology) | 5.71e-06 | 2 | 71 | 2 | DOID:0111401 (implicated_via_orthology) | |
| Disease | craniolenticulosutural dysplasia (implicated_via_orthology) | 5.71e-06 | 2 | 71 | 2 | DOID:0070307 (implicated_via_orthology) | |
| Disease | Roberts syndrome (implicated_via_orthology) | 3.41e-05 | 4 | 71 | 2 | DOID:5325 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | ARMH2 KLF13 DHX32 ZDHHC19 IGFLR1 MUC4 APOBEC3B PTTG1IP DENND4C SEC23B SMAD7 | 3.55e-04 | 1347 | 71 | 11 | EFO_0005192 |
| Disease | epilepsy (implicated_via_orthology) | 6.54e-04 | 163 | 71 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | liver cirrhosis (is_marker_for) | 1.03e-03 | 82 | 71 | 3 | DOID:5082 (is_marker_for) | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.28e-03 | 22 | 71 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | response to mTOR inhibitor | 1.65e-03 | 25 | 71 | 2 | EFO_0005417 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCAYWSQKSRCLYPG | 1981 | Q9P281 | |
| FLSWFCGNQLPAYKC | 71 | Q9UH17 | |
| LLQSVACWCYLNPVS | 121 | H3BNL8 | |
| RCSPLFFLKSCFWFQ | 431 | Q8IUA7 | |
| WLCYINSTVNPVCYA | 531 | P20309 | |
| CSDRNWYVQPCCALT | 146 | Q8N4G2 | |
| CPLCDKSCDYWNLSS | 411 | Q9NQ90 | |
| PCLFESRTQFQYCNW | 81 | Q5VTE6 | |
| KSAQVPQWCAEYCLS | 91 | Q7L7V1 | |
| CPARWQYKLAACSVS | 951 | Q76LX8 | |
| NAYKFPNLRCRGWAC | 896 | Q06278 | |
| INALCFSPNRYWLCA | 236 | P63244 | |
| CCRWNDKPYLCALYQ | 4651 | Q99102 | |
| SYQRLQDFRCLWCNS | 421 | Q5KSL6 | |
| WTLSNLCRNKNPYPC | 221 | A9QM74 | |
| KFNSPSKRYCFRCWA | 311 | O15151 | |
| NYTRWLCYCNVPQFC | 281 | Q92831 | |
| CVACSRFPNFSILYW | 86 | O95998 | |
| LVCNRTFDKYSCWPD | 56 | P47871 | |
| VSDRCKDFSLCYWNP | 71 | Q4G148 | |
| CWKPFQALCAFLISF | 206 | Q9BYJ0 | |
| LWQSFSCEAQLPYVC | 326 | O60449 | |
| RNLSCYQCFKVSSWT | 26 | H3BQJ8 | |
| KAALCYTASCQPWSC | 151 | P14151 | |
| WQNRDCSIALPYVCK | 346 | Q9UBG0 | |
| SYNILRSPCCKNAWF | 156 | Q7L622 | |
| NTLNLAPYDACWNAC | 271 | Q9NR50 | |
| LSWFCGNQLPAYKCF | 71 | Q8IUX4 | |
| NALNSCDPWVQAKCY | 1891 | Q9P2D3 | |
| KNNSYKLARWTCCAL | 426 | O15371 | |
| KPSWFGLCYCKALQS | 416 | Q01740 | |
| YWNPDNKCCSSCLQR | 31 | Q9H665 | |
| KRCYTNPPQWAKCLF | 761 | Q5VZ89 | |
| RWFQLQPSCLCYFGS | 236 | Q9H4E7 | |
| CSAKANPAVTQYRWA | 271 | Q8IZU9 | |
| PFACSWQDCNKKFAR | 196 | Q9Y2Y9 | |
| AWQSSCYRPICGSRF | 141 | Q3LI77 | |
| KCQNCFPLNWTWYSS | 181 | Q6PCB8 | |
| PECYLAACQKRDNWF | 256 | Q9ULU4 | |
| ITLYGNLWNCSCSLF | 171 | Q9H756 | |
| LVGRVNAWSCCPFQY | 266 | Q8N9Y4 | |
| KLLRFCCWENPQFSS | 2301 | Q93008 | |
| NCTNCASRDFYKWSI | 481 | Q9NTG1 | |
| RILYSTWCPADCQFA | 91 | Q6ZV89 | |
| ARVSNWPLYCLFCFG | 121 | Q9BX95 | |
| TFNKPYRCCNWKCTA | 306 | Q9UKZ4 | |
| ESRQKCPPCWYRFAN | 721 | Q9NY46 | |
| ECSPKSQRALVYWQF | 596 | Q14563 | |
| AAPCYSLASRDKNWF | 176 | Q8IXM7 | |
| CDYFPLLQLSCSDTW | 176 | Q9NZP0 | |
| NPLCQVDYRAKLWAC | 71 | Q15436 | |
| NPLCQVDYRAKLWAC | 71 | Q15437 | |
| RQKCPPCWYKFSNIF | 731 | P35498 | |
| CPKNWKSFSSNCYFI | 106 | Q9UMR7 | |
| VKNCCPLNWEYFQSS | 76 | Q9ULY5 | |
| TLAYNWNCCFIPLRL | 226 | Q9NQW8 | |
| PYRCSECWKTFSQSS | 411 | Q7Z3I7 | |
| CYTRQFISSCPCWLE | 406 | O15105 | |
| CKAINFSWRTACYKC | 686 | A0A0J9YY54 | |
| IATSLKNNKWTCPYC | 61 | Q96EQ8 | |
| KNNKWTCPYCRAYLP | 66 | Q96EQ8 | |
| KLVTVWSAPNYCYRC | 251 | O00743 | |
| TWSYTCQFCKRPVCS | 606 | Q08AE8 | |
| WPKYCCFLACIITFQ | 1166 | Q9H5I5 | |
| KPYRCQVCDTAFTWN | 621 | Q8N4W9 | |
| QRKCPPCWYKFANTF | 716 | Q9UQD0 | |
| SCLWCNTNKACLDYP | 56 | P53801 | |
| LLANPFNCNCYLAWL | 661 | O94813 | |
| YCGARWDQYKLCSTP | 421 | Q5T7W7 | |
| WDQYKLCSTPQCRQL | 426 | Q5T7W7 | |
| QGCASNWYLTICAPL | 241 | Q8WVZ1 | |
| YKFAKTFLIWNCSPC | 476 | Q01118 | |
| NYWFDLQCVCLNTPL | 1036 | Q12789 | |
| PYACTQCGKAFRWKS | 361 | Q96PQ6 | |
| NFNLWACDYVPSCLD | 106 | Q5VZQ5 | |
| AKNPNCKWYCYNDSS | 1531 | Q8NFA0 | |
| VYQFCSPSCWTKFQR | 566 | Q14202 |